Diabetic Footwear Market Size

Diabetic Footwear Market size was over USD 9.92 billion in 2024 and is anticipated to cross USD 40.36 billion by the end of 2037, witnessing more than 11.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of diabetic footwear is assessed at USD 10.82 billion. 

The growth of the market is primarily attributed to the worldwide increasing prevalence of diabetes. Moreover, these footwears are becoming popular among the people suffering from diabetes, as it reduces the risk of skin damage, and it is anticipated to increase the growth of the global diabetic footwear market. According to the data released by the World Health Organization (WHO), approximately 422 million people are currently suffering from diabetes worldwide, and this disease is directly responsible for 1.5 million deaths each year.

Diabetic footwear (shoes) is specially crafted footwear that protects the feet of diabetic patients. The growth of diabetic footwear is being fueled by the fact that this footwear offers support and protection while minimizing pressure points on the feet, lowers the risk of diabetic foot ulcers, and thereby reduces amputations, etc. It also helps to heal several diabetic conditions, such as poor blood circulation in the legs, and also addresses foot pain and ulcers. Moreover, people with diabetes have a higher risk of experiencing deep vein thrombosis (DVT). Thus, diabetic shoes are used to lessen the consequences of DVT. According to the Centers for Disease Control and Prevention (CDC), in the United States, almost 900,000 people are directly affected by deep vein thrombosis (DVT) each year.